Venture Capital

Crunching the numbers on the first half drought for biotech IPOs


Dive Brief:• Halfway through 2022, newly priced biotech stock offerings are off to their slowest pace in years as a deepening economic downturn …

Read more

Show More

Related Articles

Back to top button